COVID-19 Vaccinations for Long-Term Care Facilities

Booster (Third) Dose Planning

The Centers for Disease Control and Prevention (CDC) is expected to recommend a booster (third) dose of COVID-19 mRNA vaccine for residents and staff at long-term care facilities (LTCFs). The Louisiana Department of Health (LDH) is committed to ensuring all licensed LTCFs in the state have access to vaccines and have a firm plan for timely on-site vaccination services to administer the third dose. All LTCFs are required to have a plan in place to administer on-site third dose COVID-19 booster vaccines.

Licensed LTCFs are ensuring on-site booster vaccinations in the following ways:
  • Partnering directly with a pharmacy that is enrolled in a federal or state COVID-19 Vaccination Program. You must confirm with them that they are available and willing to provide onsite booster doses.
  • Requesting that the Louisiana Independent Pharmacies Association (LIPA) coordinate with a local vaccine provider or vaccination team to provide on-site vaccination clinics.
  • Enrolling directly as a COVID-19 vaccine provider with the Louisiana COVID-19 Vaccination Program to order and administer the booster doses accordingly.

Latest Updates on Booster Dose Planning

  • FDA & VRBPAC: On September 17, 2021, the Food and Drug Administration’s (FDA) Vaccines and Related Biologic Products Advisory Committee (VRBPAC) voted in favor of emergency use authorization of Pfizer vaccine for booster doses for ages 65 and up and for those at high risk. The FDA is not bound to follow this vote from the advisory committee, although they typically do. The FDA will still need to approve and issue an authorization based on the VRBPAC’s vote.
  • CDC & ACIP: If the Pfizer booster is authorized by the FDA, the Center for Disease Control and Prevention (CDC) Advisory Committee of Immunization Practices (ACIP) will then need to review and develop official vaccine booster recommendations for states and providers to follow. The CDC’s ACIP is planned to meet on Thursday, September 23 and Friday, September 24, to discuss the possible booster recommendations, if FDA authorizes them. The CDC will officially announce any recommendations/guidelines after they meet.
  • LDH: If approved by the CDC’s ACIP, the Louisiana Department of Health (LDH) will issue recommendations to providers on possible booster doses to additional groups of individuals in Louisiana.

It is through these various steps with different advisory committees and governing bodies that our healthcare system can ensure that vaccines remain safe and effective for those needing them first/most.

At this point, LDH presumes that the guidance will be for the Pfizer vaccine only, and not the Moderna and Johnson & Johnson (J&J) vaccines. Booster guidance for Moderna and J&J are also expected to come at some point, but it could take several weeks. LDH is optimistic that the new Pfizer booster recommendations will be issued by the start of next week (week of September 27).

DO NOT ADMINISTER any booster (third) doses to individuals until full CDC and LDH recommendations are issued, with the exception being those eligible immunocompromised individuals that have completed the self-attestation form.

For any questions regarding COVID-19 vaccinations in Louisiana contact the Immunization Program at La.Immunization@La.gov.

Click HERE to access the State of Louisiana COVID-19 Vaccination Third Dose Medical Risk Factor Self-Attestation Form.

Timeframes for Third Dose Booster VaccinesLTCFs and their on-site vaccine providers will be expected to hold third dose COVID-19 booster vaccination clinics as soon as possible once appropriate CDC and LDH recommendations are made. Timeframes for holding clinics will be communicated directly with LTCFs and pharmacy partners.

LTCF On-site Vaccine SupportQuestions regarding on-site vaccinations at LTCFs can be directed to the Louisiana LTCF COVID-19 Vaccination Partnership Call Center:

  • Call: (Toll Free) 1-866-266-1334 | Monday - Friday 8 a.m. to 5 p.m.
  • Call: 225-241-1437
  • Email: vaccines@lipa.org

Resources

Model COVID-19 Vaccine Services Agreement

Developed by LIPA, this sample agreement established the service relationship between the vaccine provider and LTCF, defining the roles and responsibilities of each entity.

COVID-19 Vaccine Registration Template Developed by LIPA, this template is to be completed by the LTCF that lists staff and residents scheduled to be vaccinated. This template is to be sent to the vaccination provider in advance of on-site clinic dates.

Additional resources to help your site prepare for your third dose COVID-19 booster vaccines vaccination clinics will be made available in subsequent communications. For now, the primary focus is that all licensed LTCFs notify LDH of their plan for executing on-site third dose COVID-19 booster vaccines.

Responsibilities of Vaccination Providers

  • Schedule and coordinate on-site clinic date(s) directly with the site at a time mutually agreed on with both parties.
  • Order and provide vaccines and ancillary supplies (e.g., syringes, needles, personal protective equipment).
  • Adhere to all applicable CMS COVID-19 requirements for individuals entering the facility site.
  • Administer COVID-19 vaccine in accordance with all requirements and recommendations of the Center for Disease Control (CDC) and CDC’s Advisory Committee on Immunization Practices (“ACIP”).
  • Provide on-site administration of the vaccine to residents and staff for whom the request is submitted in compliance with Safe Vaccine Administration standards during COVID-19.
  • Ensure cold chain management for vaccines is maintained at all times.
  • Provide COVID-19 Vaccine Information/ Screening Form for the facility to duplicate and have completed for each resident and/or employee for whom services are requested.
  • Obtain and review COVID-19 Vaccine Information/Screening Form for each person scheduled to receive the vaccine prior to vaccine administration and attach CDC Vaccine Record if available.
  • Ensure participants receiving the vaccine are provided with information contained in the appropriate EUA (Emergency Use Authorization) Fact Sheet for Recipients and Caregivers until full FDA authorization has been approved.
  • Confirm COVID vaccination status by reviewing LINKS (Louisiana’s Immunization Information System) and that a booster vaccine is appropriate, prior to vaccine administration.
  • Provide post-vaccination monitoring for all patients in the administration area not being directly monitored by facility members (e.g. patient rooms).
  • Issue and/or update CDC Vaccine Record cards to patients verifying they have been immunized or have received booster vaccine.
  • Report required vaccination data to LINKS within 24 hours of administering each dose.
  • Bill any insurance for reimbursement of the COVID vaccine administration fee or HRSA for persons who are uninsured.
  • Provide reporting on COVID-19 vaccine administration onsite at the facility location that may be requested by the Louisiana Department of Health (LDH), including but not limited to Daily COVID Vaccine Report.

Responsibilities of LTCFs

  • Provide a direct point of contact for COVID-19 vaccination event coordination (name, e-mail, phone number).
  • Schedule and coordinate on-site clinic date(s) directly with Provider.
  • Complete an Excel spreadsheet with demographic information for all persons scheduled to receive a COVID vaccine on the date of a site visit for purposes of verifying COVID vaccine status in LINKS, and transmit via e-mail to Provider.
  • Coordinate patient/staff availability for the date of the event and schedule vaccines at intervals mutually agreed on with the provider.
  • Provide a common area or location for vaccinations and monitoring to occur. The common area for vaccines should be able to accommodate safe social distancing practices and be a minimum of 10 x 10 feet with a table, two chairs, and an electrical outlet.
  • If a resident is unable to receive a vaccination in a common area and the Provider must administer in another location such as a resident’s room, the facility will be responsible for providing an observer for the recommended 15-30 minutes of monitoring after vaccination.
  • Provide any reporting on COVID-19 vaccine administration onsite at facility location that may be requested by the Louisiana Department of Health (LDH).

Positive COVID-19 Cases in Nursing Homes

Nursing homes are required to report positive COVID-19 cases to the Department of Health. The Department is working with each individual facility to increase testing of residents with and without symptoms; to minimize infection; and to prevent the spread of COVID-19.

The greatest risk for nursing homes is COVID-19 spreading within facilities and among vulnerable residents. A nursing home with residents who have tested positive for the illness is not a threat to the general public.

The Department is following recent CMS requirements and only certified adult care facilities are required to report the information in this report.

This information is as complete and accurate as possible. It will be reported weekly on Wednesdays. In addition, the Department is sharing aggregate totals for other adult residential facilities, which are not certified. This information will be shared on Wednesdays through a Department news release.

Nursing Home Deaths by Race

%NH Deaths

American Indian/Alaska Native

0.2%

Asian

0.5%

Black

30.6%

Native Hawaiian/Other Pacific Islander

0.1%

Other

0.1%

White

68.4%

Nursing Home Report

2021

 

 

2020 

 

Other Adult Residential Facilities

As of 09/22/2021: 

  • 4 COVID cases have been reported among residents of other adult residential facilities last week.
  • COVID deaths have been reported among residents of other adult residential facilities last week.